Our board consists of the chair, eight non-executive directors, the chief executive and three executive directors.

Click on the links below to view each profile:


Photo of Bob Alexander
Bob Alexander, acting chair

Bob Alexander is currently the independent chair of Sussex Health and Care Partnership. Until early 2018 Bob was deputy chief executive and executive director of resources at NHS Improvement. He has previously held the positions of chief executive and director of finance at the Trust Development Authority. From 1st April 2021 Bob takes up the role of acting chair, previously he was a non-executive director of the Trust.

Bob chairs the Trust Board and the Redevelopment Committee.

Register of interests

  • Independent chair: Sussex Health and Care Partnership
  • Non-executive director: Community Health Partnerships
  • Trustee: Demelza Children's Hospice

Andrew Bush

Professor Andrew Bush, non-executive director

Andrew Bush is professor of paediatrics and paediatric respirology, National Heart and Lung Institute, Imperial College, and consultant paediatric chest physician, Royal Brompton Harefield NHS Foundation Trust.

His research interests are in the field of paediatric respiratory medicine, especially invasive and non-invasive assessment of airway inflammation in asthma and cystic fibrosis and clinical respiratory physiology. He is the chief investigator for recently awarded £4.64 million Wellcome Trust Strategic award (“Breathing Together”). He has supervised 47 MD and PhD degrees, authored nearly 650 papers in peer review journals, and written more than 130 chapters in books and monographs. He has been deputy editor of the American Journal of Respiratory and Critical Care Medicine (the highest impact factor respiratory journal, the only deputy editor from outside North America), and head of the Paediatric Assembly of the European Respiratory Society. He was the joint editor in chief of Thorax, then the second-ranked chest journal in the world, and top-ranked outside North America, the first paediatrician to hold this post. He has served as Chair of the Publications Committee of the European Respiratory Society, and is currently Guidelines Director elect of the same society, his mandate will be 2021-4.

Andrew chairs the Quality Committee and is a member of the Audit, Risk and Governance Committee.

Register of interests

  • Clinical Training Fellowship in Global Health awarded by Imperial College to Dr Sara-Jane Smith, £12,000, AB sponsor, 2017
  • Research support from IC Trust (Dr Wynne Smith, PhD), AB PI, £81,733.00, 2017
  • AUK Senior Clinical Fellowship awarded to Dr Louise Fleming, £249,654, AB Sponsor, 2017
  • NIHR Training Fellowship awarded to Dr Sam Irving, £204,172, AB Supervisor
  • A platform clinical trial approach to the management of Mycobacterium abscessus complex, MRFF LCTRC (Australia), Associate Investigator AB, CI Prof Claire Wainwright, AUS$ 2 million, Jan 2018-Dec 2022
  • Pseudomonas aeruginosa Strategic Research Centre, UK CF Research Trust, AB CoI, CI Professor Jane Davies, £750,000 over 3 years, 2018-2021
  • PI in the Asthma UK Centre for Applied Research Renewal, Asthma UK, Director Prof Aziz Sheikh, co-Director Prof Chris Griffiths, £2 million, 2019-2024
  • MR/S002359/1, Co-Investigator, Lung function trajectories from birth to school age in African children, and their early life determinants. MRC, PI Prof Adnan Custovic, £958K, 2018-2021
  • MR/S025340/1, Co-Investigator, UNICORN: Unified Cohorts Research Network, MRC, PI Prof Adnan Custovic, FEC £3 million, MRC contribution £2.4 million, 2019-23
  • From the Sobell Foundation, £231,000 over 3 years to fund a complex respiratory care nurse, 2019-2022
  • From the USCFF, $3,602,744 over 3 years, PI Prof Claire Wainwright, Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMAT: Award number WAINWR19A0) , 2019-2022
  • From the Imperial College Trust, £74511 for a PhD Studentship for Dr Katie Bonner
  • From the Health Research Council of New Zealand, “RCT budesonide-formoterol vs salbutamol reliever therapy in childhood asthma”, 20/389, PI Prof Richard Beasley, £719,750, 3 years from July 2020
  • From Imperial College/Sobell Foundation, £101,000 over 3 years for an AUKCAR PhD non-clinical studentship studying the role of point of care blood eosinophil counts in school age and adult asthma, 2020-2023
  • Academic Adviser, HEE/NIHR ICA Pre-doctoral Clinical Academic Fellowship awarded to Jennie Balls, £29,161 over one year, October 2020

Peter Goldsbrough
Peter Goldsbrough, non-executive director

Peter Goldsbrough is a senior leader experienced in the private and public sectors. Peter was a managing director at The Boston Consulting Group and is now a senior advisor to the firm. He is also a visiting professor at the Institute of Global Health Innovation, Imperial College. He has previously served as a non-executive director with NHS London. He has many years’ experience working with healthcare, pharmaceutical and academic organisations as well as substantial financial management expertise.

Peter advises senior leaders of major organisations in a variety of industrial and service sectors on strategic direction and operational performance. He has specialised in the leadership of large-scale operational and organisational change. His geographic experience covers the UK, Europe, the US, Asia and Australasia.

He was educated at Cambridge University and the Harvard Business School.

Peter chairs the Remuneration and Appointments Committee and is a member of the Finance, Investment and Operations Committee, and the Redevelopment Board Committee.

Register of interests

  • Non-executive director, R J Young (Properties) Ltd
  • Non-executive director, Jenkinsons Holding Ltd
  • Senior advisor, The Boston Consulting Group
  • Trustee, Fidelity (UK) Foundation
  • Trustee, Dartington Trust
  • Visiting professor, Institute of Global Health Innovation, Imperial College London
  • Spouse, Trustee, Cancer Research UK; non executive director Vitality UK 


Andreas Raffel
Dr Andreas Raffel, non-executive director

 Dr Andreas Raffel has over 30 years of experience at board-level. He was previously executive vice chairman at Rothschild in London, and held operational leadership and strategic advisory roles in Europe, US and Asia.

Andreas has also held banking appointments at Morgan Stanley. He sits on the Board of Bristol University and chairs its Finance and Infrastructure Committee as well as sitting on the Nominations Committee. He is Deputy Chair of Change Grow Live, the UK’s largest substance abuse charity. He is Senior adviser to Rothschild as well as three Fintech companies in the UK and Germany.

Andreas is chair of the Trust’s Finance, Investment and Operations Committee and a member of the Audit, Risk and Governance Committee.

Register of interests

  • Member of the International Advisory Board, Cranfield School of Management
  • Deputy Chair, Change Grow Live (CGL)
  • Member of board of trustees, Bristol University
  • Senior adviser, Rothschild
  • Senior adviser, Flagstone Investment Management
  • Senior adviser, Moonfare
  • Senior adviser, 2RSquared


Nick Ross
Nick Ross, non-executive director

Nick Ross is best known as a broadcaster and journalist but has many years of experience in healthcare, bioethics and evidence-based public policy. He has been appointed to several Department of Health advisory roles including an NHS review board in regulating gene therapy. He served on the Nuffield Council on Bioethics, on the Academy of Medical Sciences inquiry into the use of non-human primates in research, the Royal College of Physicians committee on ethical issues in medicine, and chaired the advisory board for the Wales Cancer Bank. He is a member of the clinical research steering committee of the Royal College of Surgeons, and the ethics board of the UK Biobank.

Nick is president, chair or patron of several health-related charities including Healthwatch and Sense About Science. He has an honorary doctorate from Queen’s University Belfast and is an honorary fellow of the Royal College of Physicians, the Royal College of Surgeons, the Royal Society of Medicine and of University College London.

Nick is a member of the Remuneration and Appointments Committee, and the Redevelopment Board Committee. He also represents the Trust on the board of Imperial Health Charity.

Register of interests

  • Member, RCS research steering group
  • Trustee, UK Stem Cell Foundation
  • Member, UK Biobank ethics committee
  • Affiliate, James Lind Alliance
  • President, HealthWatch
  • Trustee, Sense About Science
  • Trustee, Crimestoppers
  • Vice president, Institute of Advanced Motorists
  • President, The Kensington Society
  • Trustee, Imperial Health Charity board
  • Visiting Professor, UCL Jill Dando Institute of Crime Science
  • Member, Police Foundation inquiry into the future of policing
  • Chair, Westminster City Council Hate Crime Commission
  • Freelance Journalist; Broadcaster; Conference Moderator 


Portrait of Kay Boycott non-executive director
Kay Boycott, non-executive director 

Kay Boycott has a wealth of cross-sector experience in both executive and non-executive roles.

She began her career in commercial roles for Nestlé Rowntree and Johnson & Johnson; followed by a decade in strategy consultancy for global clients and UK Government departments. In this period she also served as a Non-executive Director and Finance and Audit Committee Chair of a local NHS Trust.

Kay moved to the charity sector with a Director role at Shelter, the housing charity. She was Chief Executive of Asthma UK, and the first Chief Executive of Asthma UK and the British Lung Foundation Partnership having led them through merger and post-merger integration. She has experience in patient centred innovation, digital transformation, health policy and cross sector health research and innovation partnerships.

In 2020 she moved to a fully plural career as a non-executive director and independent advisor to a variety of clients primarily in the healthcare sector.

Kay is the interim chair of the Trust’s Audit, Risk and Governance Committee and is a member of the Quality Committee and People Committee.


Register of interests

  • Lay member of Council and Audit and Risk Committee Chair, Durham University
  • Non-Executive Director, Eakin Healthcare Group
  • Independent audit committee member, London Fire Brigade
  • Non-Executive Director, PatientMpower
  • Member, Kings Fund General Advisory Council



Photo of Sim Scavazza, non-executive director

Sim Scavazza, non-executive director

Sim Scavazza is a retail and fashion specialist with 30 years’ experience in the sector, working in buying and merchandising for some of the leading retailers in the UK. Sim is deputy chair of the University of the Arts London and was previously chair of the Mentor UK for over 10 years, protecting children and young people from the harms of alcohol and substance misuse. She joined us as a designate non-executive director on 1 October 2020 and took up the non-executive position from 1 December 2020.

Sim is the chair of the People Committee and is a member of the Quality Committee, Audit, Risk and Governance Committee and Redevelopment Committee.

Register of interests

  • Special Advisor on Race for NHS Providers





Portrait of Dr Ben Maruthappu associate non-executive director
Dr Ben Maruthappu, associate non-executive director

Ben is a London-based doctor serving as Co-founder & CEO of Cera, a multi-award winning technology company transforming social care. In just over four years he has grown Cera from zero to £200m revenues, 10,000 employees, now delivering 40,000 healthcare visits a day, making it one of Europe's fastest growing businesses.

Formerly, he advised the CEO of NHS England on £100 billion of health spending, co-founding the NHS Innovation Accelerator (NIA) which benefitted three million people in its first six months. He has a strong interest in research with over 100 peer-reviewed publications and 75 academic awards. Ben has advised a range of organisations, from startups to multilaterals, including the Swiss government, Bain & co. and the WHO. He is Chairman of the UK Medical Students’ Association (UKMSA), and has authored three medical books.

Ben was educated at Oxford, Cambridge and Harvard universities. He was listed in WIRED’s Top 10 Innovators in Healthcare, named Disruptive Leader of the Year and awarded an MBE in the 2020 Queen's New Years Honours list.

Register of interests

  • CEO, Cera Care
  • Board member & Trustee, Skills for Care
  • Board member, NHS Innovation Accelerator
  • Board member, Kingdom Bank Ltd
  • Senior Adviser, Bain & Company
  • Advisory Group Member, Centene UK


A photo of Beverley Ejimofo, non-executive director

Beverley Ejimofo, associate non-executive director

Beverley Ejimofo is an experienced consultant and the founding director of two organisations. She has worked with and trained public sector organisations, charities, community groups, and local and central government departments.

Beginning in October 2020, Beverley joined the Trust’s non-executive team on a 12-month placement as part of the NExT Director scheme and has since been appointed as an associate non-executive director.

Register of interests

  • Curate: St George's with St Barnabas Church, Beckenham.




Tim Orchard
Professor Tim Orchard, chief executive

Tim is a consultant physician and gastroenterologist, joining the organisation as a registrar in 2000. He completed his undergraduate medicine degree at Cambridge.

Tim is renowned for his work in the field of inflammatory bowel disease (IBD), and has been the chair of the IBD section of the British Society of Gastroenterology and a national representative on the European Crohn’s and Colitis Organisation.

Tim is an accomplished and published author of gastroenterology research in the field of inflammatory bowel disease and is committed to teaching. He is also professor of gastroenterology at Imperial College London. He has been the director of clinical studies at St Mary’s Hospital, and chaired the Imperial College DCS Committee. He has a Fellowship of the Higher Education Academy and, in 2000, was honoured with the Ralph Noble Prize by the University of Cambridge.

Tim was appointed chief executive at Imperial College Healthcare in June 2018.

Register of interests

  • Professor at Imperial College London
  • Member of the NICE Panel of Experts
  • Director, Imperial College Health Partners
  • Loyalty interests with pharmaceutical advisory boards
  • Medical advisor: NW London Crohn’s and Colitis UK


Julian Redhead
Professor Julian Redhead, medical director

Specialising in emergency medicine Professor Redhead was first appointed as a consultant at Ealing hospital in 2000. He joined Imperial College Healthcare NHS Trust full time in 2004 and became chief of service for emergency medicine in 2008. 

Since then he has held various roles including clinical programme group director for medicine, divisional director for investigative and supporting sciences, associate medical director for professional development and interim chief executive. 

Professor Redhead is currently also medical director of the Fortius Clinic, trustee to the Royal Society for the Prevention of Accidents, secretary to the British Association of Immediate Care for London and a Care Quality Commission specialist adviser. 

Register of interests

  • Trustee, Royal Society for the Prevention of Accidents
  • Director, Stadium Doctors Ltd
  • Shareholder, Fortius Clinic
  • Medical director, Fortius Clinic
  • Specialist adviser, Care Quality Commission
  • Major incident doctor, London Ambulance Service
  • Doctor, Chelsea Football Club
  • Shareholder,  Opus Clinic
  • CQC inspector
  • Trustee, Imperial Health Charity
  • Clinical private practice: Fortius Clinic and Imperial Private Healthcare


Jazz Thind
Jazz Thind, chief financial officer 

Jazz is a qualified accountant and joined the NHS in 1993 in a junior finance role. Since then, Jazz has taken up a number of NHS roles covering the breadth of the finance function and has been in finance leadership roles across both NHS provider and commissioning organisations. The majority of Jazz's NHS career was at Oxleas NHS Foundation Trust where she was appointed to the director of finance role in 2016. Jazz took up a secondment post at Imperial College Healthcare NHS Trust as the interim CFO in January 2020, and was appointed to the permanent role of chief financial officer in December 2020. Post-graduation and prior to joining the NHS, Jazz worked in retail and HMC.

Register of interests

  • Director of OPS (Oxleas Prison Services)
  • Director of ToPP (The Oxleas Property Partnership). 



Janice Sigsworth
Professor Janice Sigsworth CBE, director of nursing

Professor Janice Sigsworth joined the Trust in 2008 from the Department of Health where she was deputy chief nurse (England). With a clinical background in respiratory medicine and long term conditions, she has a BSc in Nursing, MSc in Health Service Management, and has honorary professorial appointments with Bucks New University, King’s College and Middlesex University.

Janice is a special trustee of the General Nursing Council for England and Wales Trust and clinical strategic adviser at the Nursing and Midwifery Council for its review of midwifery pre-registration standards. She is chair of the Shelford Safer Nursing Care Tool Steering Group and co-chair of NHSI Safe Staffing Faculty Steering Group.

Janice was awarded a CBE in the 2018 Queen’s Birthday Honours for services to nursing.

Register of interests

  • Honorary professorial appointments, King’s College London, Bucks New University and Middlesex University
  • Trustee, General Nursing Council Trust
  • Clinical adviser to the Nursing and Midwifery Council (NMC) review of pre-registration standards
  • Chair, Shelford Safer Nursing Care Tool Steering Group
  • NHSI Safe Staffing Faculty Steering Group
  • National professional lead for nursing and midwifery genomics